Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
114.00    2.50 (2.24%)
Bid:
112.00
Ask:
116.00
Spread: 4.00 (3.571%)
Market Cap: £68.59m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

24 Jul 2008 07:00

RNS Number : 7526Z
Intercede Group PLC
24 July 2008
 



24 JULY 2008

INTERCEDE GROUP PLC

("Intercede" or "the Company")

Trading Update 

Intercede, a leading producer of Identity and Credential Management Systems (IDCMS) software, today announces that in the first three months of the current financial year it has made strong commercial progress compared to the previous year.

Software deliveries to previously announced major customers in the UK, Europe and the US have been completed on time and ongoing development work is proceeding according to contractual schedules. The trading performance for the quarter ending 30 June 2008 reflects this continued progress resulting in increased revenues and reduced losses year on year. 

Further progress has also been made with the selection of Intercede's MyID technology for the following projects:

 

·; Two additional US Federal Agencies (bringing the total number served by Intercede‘s technology to 10) will be using MyID to issue secure credentials.
·; A MyID system has been installed to power a First Responder (FRAC) service in a large US state.
·; A managed service incorporating MyID has been deployed by an Intercede partner to support a large US Military Base.
·; Intercede’s first Australian MyID customer.
·; An additional UK Government contract.

 

Richard Parris, Chairman and Chief Executive of Intercede, commented:

"The level of activity in all aspects and regions of our business is greater than it has ever been and we are benefiting from participating in one of the few technology markets that is rapidly growing in spite of the general economic downturn. The overall prospects for the Group remain positive and I expect Intercede to deliver enhanced financial performance in the current financial year and beyond".

About Intercede

Intercede Group plc is a leading developer and supplier of smart card and identity management software listed on the London Stock Exchange (IGP LN) (IGP.L). Intercede's MyID software manages the secure registration, issuance and lifecycle of digital identities for a wide range of uses. This requires the integration of multiple technologies and products from many different vendors, including smart cards, biometrics, digital certificates, Open Platform applets and physical access control systems.

Intercede works with a number of market leading OEM, re-seller and technology partners that supply MyID technology to the global market place including: Athena Smartcard Solutions, Gemalto, Oberthur Card Systems, Oracle, RSA Security, SafeNet, Thales, VeriSign and a variety of systems integrators and other security product and service providers. 

Intercede and MyID are registered trademarks or trademarks in the UK, US and/or other countries. For more information visit http://www.intercede.com

ENQUIRIES

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

KBC Peel Hunt

Tel. +44 (0)20 7418 8900

Richard Kauffer

Daniel Harris

Pelham Public Relations

Archie Berens

Tel. +44 (0)20 7743 6679

Robert Koh

Tel. +44 (0)20 3170 7444

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSELFMDSASEDW
Date   Source Headline
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSNotice of Results & Investor Presentation
25th Oct 20247:00 amRNSShare Buyback Programme
11th Oct 20248:38 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTrading Update
1st Oct 20247:00 amRNSNotification of Trading Update and H1 FY25 Results
30th Sep 20247:00 amRNSContract Orders and Renewals
25th Sep 202412:51 pmRNSResult of AGM
20th Sep 202411:45 amRNSDirector/PDMR Shareholding
18th Sep 20247:00 amRNSContract Orders and Renewals
2nd Sep 20247:00 amRNSContract Orders and Subscription Renewals
30th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
4th Jul 20243:58 pmRNSIssue of Equity & Total Voting Rights
28th Jun 20243:49 pmRNSIssue of Equity & Total Voting Rights
26th Jun 20247:00 amRNSPartnership with Carahsoft Technology Corp
19th Jun 20246:25 pmRNSHolding(s) in Company
18th Jun 20249:17 amRNSHolding(s) in Company
18th Jun 20247:15 amRNSDirector/PDMR Shareholding and Issue of Equity
18th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSNotice of Results & Investor Presentation
16th May 202412:00 pmRNSCapital Markets Day - Agenda Update
14th May 20246:17 pmRNSShare Incentive Scheme
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.